{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:18:44Z","timestamp":1790716724132,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022278","name":"Fondation des Gueules Cass\u00e9es","doi-asserted-by":"publisher","award":["20-2023"],"award-info":[{"award-number":["20-2023"]}],"id":[{"id":"10.13039\/501100022278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022278","name":"Fondation des Gueules Cass\u00e9es","doi-asserted-by":"publisher","award":["24-2018"],"award-info":[{"award-number":["24-2018"]}],"id":[{"id":"10.13039\/501100022278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.heares.2026.109784","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:14:50Z","timestamp":1787411690000},"page":"109784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oxaliplatin-chemotherapy induced cochlear synaptopathy"],"prefix":"10.1016","volume":"481","author":[{"given":"Marion","family":"Souchal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Balayssac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-7503","authenticated-orcid":false,"given":"Fabrice","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2026.109784_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/frdem.2023.1199319","article-title":"Hearing loss and its link to cognitive impairment and dementia","volume":"2","author":"Azeem","year":"2023","journal-title":"Front Dement."},{"issue":"7","key":"10.1016\/j.heares.2026.109784_bib0002","first-page":"427","article-title":"Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life","volume":"32","author":"Balayssac","year":"2024","journal-title":"Support. Care Cancer."},{"issue":"4","key":"10.1016\/j.heares.2026.109784_bib0003","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1026515619443","article-title":"Hair cells in the inner ear of the pirouette and shaker 2 mutant mice","volume":"29","author":"Beyer","year":"2000","journal-title":"J. Neurocytol"},{"key":"10.1016\/j.heares.2026.109784_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s101620020044","article-title":"Effects of anesthesia on efferent-mediated adaptation of the DPOAE","volume":"3","author":"Boyev","year":"2002","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2026.109784_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10162-011-0306-z","article-title":"Sound-evoked olivocochlear activation in unanesthetized mice","volume":"13","author":"Chambers","year":"2012","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2026.109784_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.npep.2017.12.002","article-title":"Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity","volume":"67","author":"Chukyo","year":"2018","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1672-2930(13)50009-2","article-title":"Ototoxic model of oxaliplatin and protection from nicotinamide adenine dinucleotide","volume":"8","author":"Dalian","year":"2013","journal-title":"J. Otol."},{"issue":"5","key":"10.1016\/j.heares.2026.109784_bib0008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/00016489.2013.879740","article-title":"Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures","volume":"134","author":"Dammeyer","year":"2014","journal-title":"Acta Otolaryngol."},{"issue":"11","key":"10.1016\/j.heares.2026.109784_bib0009","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Review: ototoxic characteristics of platinum antitumor drugs","volume":"295","author":"Ding","year":"2012","journal-title":"Anat. Rec."},{"issue":"19","key":"10.1016\/j.heares.2026.109784_bib0010","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1523\/JNEUROSCI.5138-14.2015","article-title":"Aging after noise exposure: acceleration of cochlear synaptopathy in \"recovered\" ears","volume":"35","author":"Fernandez","year":"2015","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.heares.2026.109784_bib0011","first-page":"46","article-title":"Ototoxicity and platinum uptake following cyclic administration of platinum-based chemotherapeutic agents","volume":"49","author":"Gersten","year":"2020","journal-title":"J. Assoc. Res. Otolaryngol."},{"issue":"4","key":"10.1016\/j.heares.2026.109784_bib0012","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/AUD.0000000000001009","article-title":"Decreased reemerging auditory brainstem responses under Ipsilateral broadband masking as a marker of noise-induced cochlear synaptopathy","volume":"42","author":"Giraudet","year":"2021","journal-title":"Ear Hear."},{"issue":"4","key":"10.1016\/j.heares.2026.109784_bib0013","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/1973947815Y.0000000023","article-title":"Sudden hearing loss due to oxaliplatin use in a patient with colon cancer","volume":"28","author":"G\u00fcven\u00e7","year":"2016","journal-title":"J. ChemOther"},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jnci\/djn418","article-title":"Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity","volume":"101","author":"Hellberg","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12029-013-9489-3","article-title":"Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect","volume":"45","author":"Hijri","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"issue":"2","key":"10.1016\/j.heares.2026.109784_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/00016480802032835","article-title":"Changes in transient receptor potential vanilloid (TRPV) 1, 2, 3 and 4 expression in mouse inner ear following gentamicin challenge","volume":"129","author":"Ishibashi","year":"2009","journal-title":"Acta Otolaryngol."},{"issue":"10","key":"10.1016\/j.heares.2026.109784_bib0017","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/00005537-200310000-00009","article-title":"Contralateral suppression of distortion-product otoacoustic emissions declines with age: a comparison of findings in CBA mice with human listeners","volume":"113","author":"Jacobson","year":"2003","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.heares.2026.109784_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4251\/wjgo.v12.i2.205","article-title":"Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: a qualitative study to validate the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-neurotoxicity scale","volume":"12","author":"Kaiser","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"issue":"9","key":"10.1016\/j.heares.2026.109784_bib0019","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.heares.2026.109784_bib0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00001756-200403010-00011","article-title":"Developmental expression of two-pore domain K+ channels, TASK-1 and TREK-1, in the rat cochlea","volume":"15","author":"Kanjhan","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.heares.2026.109784_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.744085","article-title":"Colorectal cancer survivors suffering from sensory chemotherapy-induced peripheral neuropathy are not a homogenous group: secondary analysis of patients' Profiles with oxaliplatin-induced peripheral neuropathy","volume":"12","author":"Kerckhove","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.heares.2026.109784_bib0022","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12328-020-01166-9","article-title":"Neoplastic meningitis due to colorectal cancer","volume":"13","author":"Kidate","year":"2020","journal-title":"Clin. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7874\/kja.2012.16.1.14","article-title":"Effect of isoflurane on the hearing in mice","volume":"16","author":"Kim","year":"2012","journal-title":"Korean J. Audiol."},{"issue":"5","key":"10.1016\/j.heares.2026.109784_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4166\/kjg.2020.121","article-title":"Oxaliplatin-induced sudden hearing loss in a patient with pancreatic cancer","volume":"76","author":"Kim","year":"2020","journal-title":"Korean J. Gastroenterol."},{"issue":"45","key":"10.1016\/j.heares.2026.109784_bib0025","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1523\/JNEUROSCI.2845-09.2009","article-title":"Adding insult to injury: cochlear nerve degeneration after \"temporary\" noise-induced hearing loss","volume":"29","author":"Kujawa","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heares.2026.109784_bib0026","doi-asserted-by":"crossref","unstructured":"Lacey C, Clark K, Debacker JR, Stuehm H, Hungerford M, Milnes T, Johansson K, Mannino R, Graff JN, Konrad-Martin D. (2026) Identifying gaps and opportunities to improve ototoxicity management in veterans with cancer: evidence from a retrospective cohort and oncology provider survey. Cancer Med.. 15(2):e71566. doi: 10.1002\/cam4.71566.","DOI":"10.1002\/cam4.71566"},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/ijms23010098","article-title":"The class I HDAC inhibitor, MS-275, prevents oxaliplatin-induced chronic neuropathy and potentiates its antiproliferative activity in mice","volume":"23","author":"Lamoine","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heares.2026.109784_bib0028","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"Langer","year":"2013","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.heares.2026.109784_bib0029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pharmtox-033123-114106","article-title":"Hear and now: ongoing clinical trials to prevent drug-induced hearing loss","volume":"64","author":"Lee","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.heares.2026.109784_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2006.09.016","article-title":"Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat","volume":"128","author":"Ling","year":"2007","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.heares.2026.109784_bib0031","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.celrep.2015.04.027","article-title":"The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia","volume":"11","author":"Lolignier","year":"2015","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.heares.2026.109784_bib0032","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jnr.24754","article-title":"HCN channels in the mammalian cochlea: expression pattern, subcellular location, and age-dependent changes","volume":"99","author":"Luque","year":"2021","journal-title":"Neurosci. Res."},{"issue":"6","key":"10.1016\/j.heares.2026.109784_bib0033","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/014556131008900607","article-title":"Acute ototoxicity from a single infusion of oxaliplatin","volume":"89","author":"Malhotra","year":"2010","journal-title":"Ear Nose Throat J."},{"issue":"10","key":"10.1016\/j.heares.2026.109784_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186250","article-title":"Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: phenotypic and genotypic insights","volume":"12","author":"Marmiroli","year":"2017","journal-title":"PLoS. One"},{"issue":"8","key":"10.1016\/j.heares.2026.109784_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282404","article-title":"How important are concurrent vehicle control groups in (sub)chronic non-human primate toxicity studies conducted in pharmaceutical development? An opportunity to reduce animal numbers","volume":"18","author":"Mecklenburg","year":"2023","journal-title":"PLoS. One"},{"key":"10.1016\/j.heares.2026.109784_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2025.105707","article-title":"The gold standard control groups in physiological and pharmacological research are not that shiny: intraperitoneal saline injection and needle pricking affect prepubescent mice's behavior in a sex-specific manner","volume":"169","author":"Moraes","year":"2025","journal-title":"Horm. Behav."},{"issue":"1\u20132","key":"10.1016\/j.heares.2026.109784_bib0037","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.heares.2004.08.011","article-title":"A physiological place-frequency map of the cochlea in the CBA\/J mouse","volume":"202","author":"M\u00fcller","year":"2005","journal-title":"Hear. Res."},{"issue":"2","key":"10.1016\/j.heares.2026.109784_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0196-0709(88)80007-3","article-title":"Quantification of human spiral ganglion cells by serial section reconstruction and segmental density estimates","volume":"9","author":"Nadol","year":"1988","journal-title":"Am. J. Otolaryngol."},{"issue":"16","key":"10.1016\/j.heares.2026.109784_bib0039","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1523\/JNEUROSCI.0013-05.2005","article-title":"Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing","volume":"25","author":"Nagata","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.heares.2026.109784_bib0040","first-page":"676","article-title":"Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer","volume":"14","author":"Oh","year":"2013","journal-title":"JOP"},{"issue":"11","key":"10.1016\/j.heares.2026.109784_bib0041","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14992027.2019.1660918","article-title":"Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review","volume":"58","author":"Pearson","year":"2019","journal-title":"Int. J. Audiol."},{"issue":"12","key":"10.1016\/j.heares.2026.109784_bib0042","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.pain.2014.09.013","article-title":"Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception","volume":"155","author":"Pereira","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.heares.2026.109784_bib0043","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2018.07.026","article-title":"Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin","volume":"140","author":"Poupon","year":"2018","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.heares.2026.109784_bib0044","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/phar.2478","article-title":"Drug-induced Ototoxicity: a comprehensive review and reference guide","volume":"40","author":"Rizk","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.heares.2026.109784_bib0045","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/cancers12051266","article-title":"Assessment and management of platinum-related ototoxicity in children treated for cancer","volume":"12","author":"Romano","year":"2020","journal-title":"Cancers. (Basel)"},{"issue":"2","key":"10.1016\/j.heares.2026.109784_bib0046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.joto.2018.03.002","article-title":"Isoflurane anesthesia suppresses distortion product otoacoustic emissions in rats","volume":"13","author":"Sheppard","year":"2018","journal-title":"J. Otol."},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0047","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.heares.2026.109784_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1362315","article-title":"Assessing quality of life in childhood cancer survivors at risk for hearing loss: a comparison of HEAR-QL and PROMIS measures","volume":"14","author":"Spence","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heares.2026.109784_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6280969","article-title":"Transient abnormalities in masking tuning curve in early progressive hearing loss mouse model","volume":"2018","author":"Souchal","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"3","key":"10.1016\/j.heares.2026.109784_bib0050","first-page":"343","article-title":"Introducing the concept of virtual control groups into preclinical toxicology testing","volume":"37","author":"Steger-Hartmann","year":"2020","journal-title":"ALTEX"},{"issue":"3","key":"10.1016\/j.heares.2026.109784_bib0051","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1078155212437901","article-title":"Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent","volume":"18","author":"Vietor","year":"2012","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"3","key":"10.1016\/j.heares.2026.109784_bib0052","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3892\/mmr.2014.2922","article-title":"Expression and functional role of Nav1.9 sodium channel in cartwheel cells of the dorsal cochlear nucleus","volume":"11","author":"Yan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0053","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13046-021-02141-z","article-title":"Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.heares.2026.109784_bib0054","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3906\/sag-1304-76","article-title":"Oxaliplatin and ototoxicity: is it really safe for hearing?","volume":"44","author":"Y\u00fcce","year":"2014","journal-title":"Turk. J. Med. Sci."},{"issue":"1\u20132","key":"10.1016\/j.heares.2026.109784_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0378-5955(99)00003-9","article-title":"Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses","volume":"130","author":"Zheng","year":"1999","journal-title":"Hear. Res."},{"issue":"1","key":"10.1016\/j.heares.2026.109784_bib0057","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12868-021-00613-8","article-title":"SCN11A gene deletion causes sensorineural hearing loss by impairing the ribbon synapses and auditory nerves","volume":"22","author":"Zu","year":"2021","journal-title":"BMC. Neurosci."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595526002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595526002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:41:15Z","timestamp":1790714475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595526002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0378595526002558"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2026.109784","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin-chemotherapy induced cochlear synaptopathy","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2026.109784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109784"}}